Events - Alliance for Patient Access

Upcoming Events

March 13, 2026 6:00 pm – March 14, 2:00 pm

Alzheimer's Disease Initiative Meeting

Join AfPA's Alzheimer's Disease Initiative of the Neurological Disease Working Group for its first ever meeting in Washington, DC.

Past Events Gallery

View highlights from past events.

October 1, 2025

AfPA's 10th Annual National Policy & Advocacy Summit

Highlights >>

SEPTEMBER 24, 2024

AfPA's National Policy & Advocacy Summit

Highlights >>

NOVEMBER 2, 2023

National Policy & Advocacy Summit on Biologics

Highlights >>

MAY 22, 2023

Cardiovascular Health Policy Summit

Highlights >>

OCTOBER 19, 2022

National Policy & Advocacy Summit on Biologics

Highlights >>

AUGUST 31, 2022

Infant Health Policy Summit

Highlights >>

JUNE 9, 2022

Cardiovascular Health Policy Summit

Highlights >>

APRIL 28, 2022

Value of Innovation Policy Forum

Highlights >>

NOVEMBER 17, 2021

National Policy & Advocacy Summit on Biologics

Highlights >>

OCTOBER 6, 2021

Getting Telehealth Policy Right

Highlights >>

SEPTEMBER 2, 2021

7th Annual Infant Health Policy Summit

Highlights >>

JULY 15, 2021

2021 Cardiovascular Health Policy Summit

Highlights >>

NOVEMBER 18, 2020

National Policy & Advocacy Summit on Biologics

Highlights >>

SEPTEMBER 10, 2020

2020 Virtual Infant Health Policy Summit

Highlights >>

SEPTEMBER 12, 2019

2019 Infant Health Policy Summit

Highlights >>

MAY 16, 2019

2019 Cardiovascular Health Policy Summit

Highlights >>

APRIL 10, 2019

2019 National Policy & Advocacy Summit on Biologics and Biosimilars

Highlights >>

NOVEMBER 2, 2018

AfPA – IfPA Health Policy Leadership Retreat

Highlights >>

OCTOBER 25, 2018

2018 Infant Health Policy Summit

Highlights >>

MAY 15, 2018

2018 Cardiovascular Health Policy Summit

Highlights >>

APRIL 17, 2018

2018 National Policy & Advocacy Summit on Biologics and Biosimilars

Highlights >>

OCTOBER 26, 2017

2017 Infant Health Policy Summit

Highlights >>

APRIL 6, 2017

2017 National Policy & Advocacy Summit on Biologics and Biosimilars

Highlights >>